1008510-37-9 Usage
Uses
Used in Pharmaceutical Industry:
4-(S)-2-[(S)-2-(methoxycarbonylamino)-3-phenylpropanamido]-2-[2-(thiophen-2-yl)thiazol-4-yl]ethylphenylsulfamic acid is used as a potential therapeutic agent for targeting specific enzymes or receptors in the body. Its unique structure allows it to interact with biological targets, such as VE-PTP, which is known to play a role in various diseases. By inhibiting the activity of VE-PTP, 4-{(S)-2-[(S)-2-(methoxycarbonylamino)-3-phenylpropanamido]-2-[2-(thiophen-2-yl)thiazol-4-yl]ethyl}phenylsulfamic acid may have potential applications in treating conditions related to the dysregulation of this enzyme.
Used in Drug Development:
In the field of drug development, 4-(S)-2-[(S)-2-(methoxycarbonylamino)-3-phenylpropanamido]-2-[2-(thiophen-2-yl)thiazol-4-yl]ethylphenylsulfamic acid can be utilized as a lead compound for the design and synthesis of new drugs. Its structural features can be further optimized to improve its potency, selectivity, and pharmacokinetic properties, ultimately leading to the development of more effective therapeutic agents.
Used in Chemical Research:
4-(S)-2-[(S)-2-(methoxycarbonylamino)-3-phenylpropanamido]-2-[2-(thiophen-2-yl)thiazol-4-yl]ethylphenylsulfamic acid can also be employed in chemical research to study the interactions between small molecules and biological targets. By understanding the binding mechanisms and structural requirements for inhibition, researchers can gain valuable insights into the design of novel inhibitors and the development of targeted therapies for various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 1008510-37-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,8,5,1 and 0 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1008510-37:
(9*1)+(8*0)+(7*0)+(6*8)+(5*5)+(4*1)+(3*0)+(2*3)+(1*7)=99
99 % 10 = 9
So 1008510-37-9 is a valid CAS Registry Number.
1008510-37-9Relevant academic research and scientific papers
COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES
-
Page/Page column 243, (2014/09/29)
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for increased solubility ar
COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLS
-
Page/Page column 54, (2011/02/24)
Disclosed are methods for preventing metastasis of cancer cells. The disclosed compounds can be used to prevent the spread of tumor or other types of cancer cells.
